CLRB (STOCKS)
Cellectar Biosciences INC NEW
$2.300000
+0.070000 (+3.14%)
Prev close: $2.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- James V. Caruso
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.70M
- Employees
- 11
- P/E (TTM)
- -0.32
- P/B (TTM)
- 3.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.30 | $-1.92 | +0.6227 | +32.39% |
|
Dec 2025 (Q4)
|
$-1.29 | $-2.34 | +1.0492 | +44.85% |
|
Sep 2025 (Q3)
|
$-1.41 | $-2.58 | +1.1680 | +45.31% |
|
Jun 2025 (Q2)
|
$-3.39 | $-3.98 | +0.5880 | +14.78% |
Financial Statements
| Revenues | $0.00 |
| Costs And Expenses | $22.37M |
| Nonoperating Income/Loss | $1.53M |
| Research and Development | $11.08M |
| Operating Income/Loss | -$22.37M |
| Income/Loss From Continuing Operations After Tax | -$13.99M |
| Income/Loss From Continuing Operations Before Tax | -$20.59M |
| Net Income/Loss | -$20.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.66 |
| Diluted Earnings Per Share | -$6.66 |
| Basic Average Shares | 9,511,051 |
| Diluted Average Shares | 9,511,051 |
| Assets | $11.12M |
| Current Assets | $9.27M |
| Noncurrent Assets | $1.85M |
| Fixed Assets | $339.70K |
| Other Non-current Assets | $1.51M |
| Liabilities | $6.40M |
| Current Liabilities | $4.87M |
| Noncurrent Liabilities | $1.53M |
| Equity | $3.34M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.34M |
| Liabilities And Equity | $11.12M |
| Net Cash Flow From Operating Activities | -$18.58M |
| Net Cash Flow From Operating Activities, Continuing | -$18.58M |
| Net Cash Flow | -$709.14K |
| Net Cash Flow, Continuing | -$709.14K |
| Comprehensive Income/Loss | -$20.84M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.84M |
| Other Comprehensive Income/Loss | $0.00 |